Table 1. Correlation between the expression of Stathmin and clinical classification in OSCCs.
|
Immunostaining results (no. of patients (%))
|
||||
|---|---|---|---|---|
| Clinical classification | Total | Stathmin (−) | Stathmin (+) | P-valuea |
| Age at surgery (years) | ||||
| <60 | 22 | 8 (36) | 14 (64) | |
| 60 ⩽, <70 | 26 | 6 (23) | 20 (77) | 0.654 |
| 70⩽ | 33 | 14 (42) | 19 (58) | |
| Gender | ||||
| Male | 48 | 16 (33) | 32 (67) | 0.961 |
| Female | 33 | 12 (36) | 21 (64) | |
| T-primary tumour | ||||
| T1 | 10 | 7 (70) | 3 (30) | |
| T2 | 39 | 15 (38) | 24 (62) | 0.149 |
| T3 | 13 | 2 (15) | 11 (85) | |
| T4 | 19 | 4 (21) | 15 (79) | |
| N-regional lymph node | ||||
| N(−) | 41 | 18 (44) | 23 (56) | 0.202 |
| N(+) | 40 | 10 (25) | 30 (75) | |
| Stage | ||||
| I | 8 | 6 (75) | 2 (25) | |
| II | 21 | 11 (52) | 10 (48) | 0.035 |
| III | 13 | 4 (31) | 9 (69) | |
| IV | 39 | 7 (18) | 32 (72) | |
| Histopathologic type | ||||
| Well differentiated | 51 | 17 (33) | 34 (67) | |
| Moderately differentiated | 22 | 8 (36) | 14 (64) | 0.999 |
| Poorly differentiated | 8 | 3 (38) | 5 (62) | |
| Tumour site | ||||
| Gingiva | 27 | 6 (22) | 21 (78) | |
| Tongue | 30 | 15 (50) | 15 (50) | 0.997 |
| Buccal mocosa | 7 | 2 (29) | 5 (71) | |
| Oral floor | 10 | 3 (30) | 7 (70) | |
| Oropharynx | 7 | 1 (14) | 6 (86) | |
a
A provability of P<0.05 was defined as significant.